Bioprobes for investigating mammalian cell cycle control

Journal of Antibiotics

Volumn 51, Issue 11, 1998, Pages 973-982

  Osada, Hiroyuki ^a  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN KINASE INHIBITOR; TUBULIN;

CANCER CELL; CELL CYCLE; CELL DIVISION; DEPHOSPHORYLATION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

EID: 0031788004     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.51.973     Document Type: Review

References (62)

1. USUI, T.; M. YOSHIDA, K. ABE, H. OSADA, K. ISONO & T. BEPPU: Uncoupled cell cycle without mitosis induced by a protein kinase inhibitor, K-252a. J. Cell Biol. 115: 1275-1282, 1991
2. ABE, K.; M. YOSHIDA, T. USUI, S. HORINOUCHI & T. BEPPU: Highly synchronous culture of fibroblasts from G2 block caused by staurosporine, a potent inhibitor of protein kinases. Exp. Cell Res. 192: 122-127, 1991
3. cdc2-like kinases. Biochem. Biophys. Res. Commun. 184: 80-85, 1992
4. MEIJER, L.: Chemical inhibitors of cyclin-dependent kinases. Trend. Cell Biol. 6: 393-397, 1996
5. OSADA, H.; C.-B. CUI, R. ONOSE & F. HANAOKA: Screening of cell cycle inhibitors from microbial metabolites by a bioassay using a mouse cdc2 mutant cell line, tsFT210. Bioorg. Med. Chem. 5: 193-203, 1997
6. MURRAY, A. W.: Creative blocks: cell-cycle checkpoint and feedback controls. Nature 359: 599-604, 1992
7. SERRANO, M.; G. J. HANNON & D. BEACH: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707, 1993
8. MARSHALL, C. J.: Tumor suppressor genes. Cell 64: 313-326, 1991
9. ZHOU, W.; N. TAKUWA, M. KUMADA & Y. TAKUWA: Protein kinase C-mediated bidirectional regulation of DNA synthesis, RB protein phosphorylation, and cyclin-dependent kinases in human vascular endothelial cells. J. Biolog. Chem. 268: 23041-23048, 1993
10. RILEY, D. J.; E. Y.-H. P. LEE & W. LEE: The retinoblastoma protein: more than a tumor suppressor. Ann. Rev. Cell Biol. 10: 1-29, 1994
11. RUSTGI, A. K.; N. DYSON & R. BERNARDS: Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature 352: 541-544, 1991
12. CHELLAPAN, S. P.; S. HIEBERT, M. MUDRYJ, J. M. HOROWITZ & J. R. NEVINS: The E2F transcription factor is a cellular target for the RB protein. Cell 65: 1053-1061, 1991
13. CAO, L.; B. FAHA, M. DEMBSKI, L. TASAI, E. HARLOW & N. DYSON: Independent binding of the retinoblastoma protein and p 107 to the transcription factor E2F. Nature 355: 176-179, 1992
14. RESNITZKY, D.; M. GOSSEN, H. BUJARD & S. I. REED: Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell Biol. 14: 1669-1679, 1994
15. POON, R. Y.; M. S. CHAU, K. YAMASHITA & T. HUNTER: The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res. 57: 5168-5178, 1997
16. QUELE, D. E.; R. A. ASHMUN, S. J. SHURTLEF, J. HATO, D. B.-SAGI, M. F. ROUSSEL & C. J. SHERR: Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes. Develop. 7: 1559-1571, 1993
17. BALDIN, V.; J. LUKAS, M. J. MARCOTE, M. PAGANO & G. DRAETTA: Cyclin D is a nuclear protein required for cell cycle progression in G1. Genes Develop. 7: 812-821, 1993
18. BEERMAN, T. A.; R. POON & I. H. GOLDBERG: Single-strand nicking of DNA in vitro by neocarzinostatin and its possible relationship to the mechanism of drug action. Biochim. Biophys. Acta 475: 294-306, 1977
19. MULLER, W. E.; A. MAIDHOF, J. ARENDES, W. GEURTSEN, R. K. ZAHN & R. SCHMIDSEDER: Additive effects of bleomycin and neocarzinostatin on degradation of DNA, inhibition of DNA polymerase beta, and cell growth. Cancer Res. 39: 3768-3773, 1979
20. TAKESHITA, M.; L. S. KAPPEN, A. P. GROLLMAN, M. EISENBERG & I. H. GOLDBERG: Strand scission of deoxyribonucleic acid by neocarzinostatin, auromomycin, and bleomycin: studies on base release and nucleotide sequence specificity. Biochemistry 20: 7599-7606, 1981
21. IKEGAMI, S.; T. TAGUCHI, M. OHASHI, M. OGURO, H. NAGANO & Y. MANO: Aphidicolin prevents mitotic cell division by interfering with the activity of polymerase-alpha. Nature 275: 458-460, 1978
22. cdc2/cyclin B. Cancer Res. 52: 1823-1829, 1992
23. VERDE, F.; J.-M. BERREZ, C. ANTONY & E. KARSENTI: Taxol-induced microtubule asters in mitotic extract of Xenopus eggs: requirement for phosphorylated factors and cytoplasmic dynein. J. Cell Biology 112: 1177-1187, 1991
24. 3H] vinblastine to embryonic chick brain tubulin and tubulin from sea urchin sperm tail outer doublet microtubules. Biochemistry 14: 5586-5592, 1975
25. KUMAR, N.: Taxol-induced polymerization of purified tubulin. Mechanism of action. J. Biol. Chem. 256: 10435-10441, 1981
26. MINEO, C.; Y. MURAKAMI, Y. ISHIMI, F. HANAOKA & M. YAMADA: Isolation and analysis of a mammalian temperature-sensitive mutant defective in G2 functions. Exp. Cell Res. 167: 53-62, 1986
27. CUI, C.-B.; H. KAKEYA, G. OKADA, R. ONOSE, M. UBUKATA, I. TAKAHASHI, K. ISONO & H. OSADA: Tryprostatins A and B, novel mammalian cell cycle inhibitors produced by Aspergillus fumigatus. J. Antibiotics 48: 1382-1384, 1995
28. CUI, C.-B.; H. KAKEYA & H. OSADA: Spirotryprostatin a novel mammalian cell cycle inhibitor produced by Aspergillus fumigatus. J. Antibiotics 49: 787-790, 1996
29. CUI, C.-B.; M. UBUKATA, H. KAKEYA, R. ONOSE, G. OKADA, I. TAKAHASHI, K. ISONO & H. OSADA: Acetophthalidin, a novel inhibitor of mammalian cell cycle, produced by a fungus isolated from a sea sediment. J. Antibiotics 49: 216-220, 1996
30. CUI, C.-B.; H. KAKEYA & H. OSADA: Novel mammalian cell cycle inhibitors, spirotryprostatins A and B, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase Tetrahedron 52: 12651-12666, 1996
31. CUI, C.-B.; H. KAKEYA & H. OSADA: Novel mammalian cell cycle inhibitors, cyclotryprostatins A-D, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase. Tetrahedron 53: 59-72, 1997
32. KITAGAWA, M.; H. HIGASHI, I. SUZUKI-TAKAHASHI, T. OKABE, H. OGINO, Y. TAYA, S. NISHIMURA & A. OKUYAMA: A cyclin-dependent kinase inhibitor, butyro-lactone I, inhibits phosphorylation of RB protein and cell cycle progression. Oncogene 9: 2549-2557, 1994
33. OSADA, H.; H. TAKAHASHI, K. TSUNODA, H. KUSAKABE & K. ISONO: A new inhibitor of protein kinase C, RK-286C (4′-demethylamino-4′-hydroxystaurosporine). I. Screening, taxonomy, fermentation and biological activity. J. Antibiotics 43: 163-167, 1990
34. OSADA, H.; H. KOSHINO, T. KUDO, R. ONOSE & K. ISONO: A new inhibitor of protein kinase C, RK-1409 (7-oxostaurosporine). I. Taxonomy and biological activity. J. Antibiotics 45: 189-194, 1992
35. KOSHINO, H.; H. OSADA, S. AMANO, R. ONOSE & K. ISONO: A new inhibitor of protein kinase C, RK-1409B (4′-demethylamino-4′-hydroxy-3′-epistaurosporine). J. Antibiotics 45: 1428-1432, 1992
36. URAMOTO, M.; C. J. KIM, K. SHINYA, H. KUSAKABE & K. ISONO: Isolation and characterization of phosmidosine a new antifungal nucleotide antibiotic. J. Antibiotics 44: 375-381, 1991
37. MATSUURA, M.; R. ONOSE & H. OSADA: Morphology reversion activity of phosmidosine and phosmidosine B, a newly isolated derivative, on src transformed NRK cells. J. Antibiotics 49: 361-365, 1996
38. KAKEYA, H.; R. ONOSE, P. C. LIU, C. ONOZAWA, F. MATSUMURA & H. OSADA: Inhibition of cyclin D1 expression and phosphorylation of retinoblastoma protein by phosmidosine, a nucleotide antibiotic. Cancer Res. 58: 704-710, 1998
39. WALTON, K. M. & J. E. DIXON: Protein tyrosine phosphatases. Annu. Rev. Biochem. 62: 101-120, 1993
40. DUNPHY, W. G. & A. KUMAGAI: The cdc25 protein contains an intrinsic phosphatase activity. Cell 67: 189-196, 1991
41. SUN, H.; C. H. CHARLES, L. F. LAU & N. K. TONKS: MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75: 487-493, 1993
42. ISHIBASHI, T.; D. P. BOTTARO, A. CHAN, T. MIKI & S. A. AARONSON: Expression cloning of a human dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA 89: 12170-12174, 1992
43. HAMAGUCHI, T.; T. SUDO & H. OSADA: RK-682, a potent inhibitor of tyrosine phosphatase, arrested the mammalian cell cycle progression at G1 phase. FEBS Lett. 372: 54-58, 1995
44. SHINAGAWA, S.; M. MUROI, R. ITO & T. HIDA: Tetronic acid derivatives. JP5-43568, 1993
45. ROGGO, B. E.; F. PETERSEN, R. DELMENDO, H.-B. JENNY, H. H. PETER & J. ROESEL: 3-Alkanoyl-5-hydroxymethyl tetronic acid homologue and resistomycin: New inhibitors of HIV-1 protease. J. Antibiotics 47: 136-142, 1994
46. SODEOKA, M.; R. SAMPE, T. KAGAMIZONO & H. OSADA: Asymmetric synthesis of RK-682 and its analogs, and evaluation of their protein phosphatase inhibitory activities. Tetrahedron Lett. 37: 8775-8778, 1996
47. IMBERT, V.; J.-F. PEYRON, D. F. FAR, B. MARI, P. AUBERGER & B. ROSSI: Induction of tyrosine phosphorylation and T-cell activation by vanadate peroxide, an inhibitor of protein tyrosine phosphatases. Biochem. J. 297: 163-173, 1994
48. TERADA, Y.; M. TATSUKA, S. JINNO & H. OKAYAMA: Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation. Nature 376: 358-362, 1995
49. GYURIS, J.; E. GOLEMIS, H. CHERTKOV & R. BRENT: Cdi1, a human G1 and S phase protein phosphatase that associates with cdk2. Cell 75: 791-803, 1993
50. KAGAMIZONO, T.; T. HAMAGUCHI, T. ANDO, K. SUGAWARA. T. ADACH & H. OSADA: Phosphatoquinones A and B, novel ryrosine phosphatase inhibitors produced by Streptomyces sp. R7134. submitted to J. Antibiotics
51. MORINO, T.; A. MASUDA, M. YAMADA, M. NISHIMOTO, T. NISHIKIORI & S. SAITO: Stevastelins, novel immunosuppressants produced by Penicillium. J. Antibiotics 47: 1341-1343, 1994
52. HAMAGUCHI, T.; A. MASUDA, T. MORINO & H. OSADA: Stevastelins, a novel group of immunosuppressants, inhibit dual-specificity protein phosphatases. Chemistry & Biology 4: 279-286, 1997
53. USUI, T.; G. MARRIOTT, M. INAGAKI & H. OSADA: Phoslactomycin F: Another specific inhibitor of protein phosphatase 2A. submitted to J. Biochem.
54. BANERJEE, A. C. & B. BHATTACHARYYA: Colcemid and colchicine binding to tubulin. Similarity and dissimilarity. FEBS Lett. 99: 333-336, 1979
55. OWELLEN, R. J.; A. H. OWENS, Jr. & D. W. DONIGIAN: The binding of vincristine, vinblastine and colchicine to tubulin. Biochem. Biophys. Res. Commun. 47: 685-691, 1972
56. FELLOUS, A.; R. F. LUDUENA, V. PRASAD, M. A. JORDAN, W. ANDERSON, R. OHAYON & P. T. SMITH: Effects of Tau and MAP2 on the interaction of maytansine with tubulin: inhibitory effect of maytansine on vinblastine-induced aggregation of tubulin. Cancer Res. 45: 5004-5010, 1985
57. KOBAYASHI, S.; K. TSUCHIYA, T. HARADA, M. NISHIDE, T. KUROKAWA, T. NAKAGAWA, N. SHIMADA & K. KOBAYASHI: Pironetin, a novel plant growth regulator produced by Streptomyces sp. NK10958. I. Taxonomy, production, isolation and preliminary characterization. J. Antibiotics 47: 697-702, 1994
58. KOBAYASHI, S.; K. TSUCHIYA, T. KUROKAWA, T. NAKAGAWA, N. SHIMADA & Y. IITAKA: Pironetin, a novel plant growth regulator produced by Streptomyces sp. NK10958. II. Structural elucidation. J. Antibiotics 47: 703-707, 1994
59. KONDOH, M.; T. USUI, S. KOBAYASHI, K. TSUCHIYA, K. NISHIKAWA, T. NISHIKIORI, T. MAYUMI & H. OSADA: Cell cycle arrest and antitumor activity of pironetin and its derivatives. Cancer Lett. 126: 29-32, 1998
60. CUI, C.-B.; H. KAKEYA & H. OSADA: Novel mammalian cell cycle inhibitors, tryprostatins A, B and other diketopiperazines produced by Aspergillus fumigatus. II. Physico-chemical properties and structures. J. Antibiotics 49: 534-550, 1996
61. CUI, C.-B.; H. KAKEYA, G. OKADA, R. ONOSE & H. OSADA: Novel mammalian cell cycle inhibitors, tryprostatins A, B and other diketopiperazines produced by Aspergillus fumigatus. I. Taxonomy, fermentation, isolation and biological properties, J. Antibiotics 49: 527-533, 1996
62. USUI, T.; M. KONDOH, C.-B. CUI, T. MAYUMI & H. OSADA: Tryprostatin A, a specific and novel inhibitor of microtubule assembly. Biochem. J. 333: 543-548, 1998